Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5

作者: Andrew S. Felts , Alice L. Rodriguez , Ryan D. Morrison , Katrina A. Bollinger , Daryl F. Venable

DOI: 10.1016/J.BMCL.2017.09.042

关键词:

摘要: Abstract Based on a hypothesis that an intramolecular hydrogen bond was present in our lead series of picolinamide mGlu 5 NAMs, we reasoned inactive nicotinamide could be modified through introduction fused heterocyclic core to generate potent NAMs. In this Letter, describe the synthesis and evaluation compounds demonstrate viability approach. Selected analogs were profiled variety vitro assays, two evaluated rat pharmacokinetic studies mouse model obsessive-compulsive disorder. Ancillary pharmacology screening revealed members exhibited moderate inhibition dopamine transporter (DAT), SAR developed expanded selectivity for versus DAT.

参考文章(30)
Brian Davies, Tim Morris, Physiological Parameters in Laboratory Animals and Humans Pharmaceutical Research. ,vol. 10, pp. 1093- 1095 ,(1993) , 10.1023/A:1018943613122
Julie L. Engers, Alice L. Rodriguez, Leah C. Konkol, Ryan D. Morrison, Analisa D. Thompson, Frank W. Byers, Anna L. Blobaum, Sichen Chang, Daryl F. Venable, Matthew T. Loch, Colleen M. Niswender, J. Scott Daniels, Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte, Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents Journal of Medicinal Chemistry. ,vol. 58, pp. 7485- 7500 ,(2015) , 10.1021/ACS.JMEDCHEM.5B01005
Hassan Pajouhesh, George R. Lenz, Medicinal chemical properties of successful central nervous system drugs. Neurorx. ,vol. 2, pp. 541- 553 ,(2005) , 10.1602/NEURORX.2.4.541
Qing Wang, Joseph D. Rager, Kathryn Weinstein, Paula S. Kardos, Glenn L. Dobson, Jibin Li, Ismael J. Hidalgo, Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. International Journal of Pharmaceutics. ,vol. 288, pp. 349- 359 ,(2005) , 10.1016/J.IJPHARM.2004.10.007
Boadie W. Dunlop, Charles B. Nemeroff, The Role of Dopamine in the Pathophysiology of Depression Archives of General Psychiatry. ,vol. 64, pp. 327- 337 ,(2007) , 10.1001/ARCHPSYC.64.3.327
Li Di, Haojing Rong, Bo Feng, Demystifying brain penetration in central nervous system drug discovery. Miniperspective. Journal of Medicinal Chemistry. ,vol. 56, pp. 2- 12 ,(2013) , 10.1021/JM301297F
Maarten E.A. Reith, Bruce E. Blough, Weimin C. Hong, Kymry T. Jones, Kyle C. Schmitt, Michael H. Baumann, John S. Partilla, Richard B. Rothman, Jonathan L. Katz, Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter ☆ Drug and Alcohol Dependence. ,vol. 147, pp. 1- 19 ,(2015) , 10.1016/J.DRUGALCDEP.2014.12.005
Alexia Thomas, April Burant, Nghiem Bui, Deanna Graham, Lisa A. Yuva-Paylor, Richard Paylor, Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety Psychopharmacology. ,vol. 204, pp. 361- 373 ,(2009) , 10.1007/S00213-009-1466-Y
Kyle A. Emmitte, mGlu5 negative allosteric modulators: a patent review (2013 - 2016). Expert Opinion on Therapeutic Patents. ,vol. 27, pp. 691- 706 ,(2013) , 10.1080/13543776.2017.1280466
Nancy R. Zahniser, Alexander Sorkin, Rapid regulation of the dopamine transporter: role in stimulant addiction? Neuropharmacology. ,vol. 47, pp. 80- 91 ,(2004) , 10.1016/J.NEUROPHARM.2004.07.010